Clinical Trial Update: OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

View source ↗

Summary

The OMNI Study, a Medtronic device trial evaluating therapies in pacemakers, defibrillators, and cardiac resynchronization therapy devices, was terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Heart Failure
• Ventricular Dysfunction
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Tachycardia, Ventricular, Heart Failure, Congestive | Status: TERMINATED | Results posted: 2013-08-28